Idorsia SFr200 million 0.75% convertible notes issue

Overview:

• Swiss pharmaceutical company Idorsia completed the placement of SFr200 million 0.75% convertible notes due 2024.
• The private placement took place alongside its offering of 11,912,000 new shares via accelerated bookbuilding.
• The offer price was set at SFr25.62.
• Gross proceeds of the combined offering is SFr505 million and will be used to finance the research and development pipeline of the company.

Mihail Georgiev/Rajeeb Gurung - Data analyst/Researcher